News from NORD

More Than 100 Patient Organizations Join NORD in Supporting the RARE Act


 

NORD has sent a letter to Congress, signed by more than 100 patient advocacy organizations, in support of the Rare disease Advancement, Research, and Education Act of 2018 (H.R.5115) or the “RARE Act of 2018.” Read NORD’s letter to see how this proposed legislation would help patients and families affected by rare diseases, medical researchers, and clinicians seeking to provide optimal care for their patients.

Recommended Reading

Guidance coming for mTOR inhibitors in infantile TSC
MDedge Pediatrics
Myelin antibody predicts ADEM relapse
MDedge Pediatrics
Maintenance chemo boosts survival for youth with high-risk rhabdomyosarcoma
MDedge Pediatrics
FDA approves Epidiolex for Lennox-Gastaut syndrome and Dravet syndrome
MDedge Pediatrics
Limited anakinra course often enough for systemic JIA if used first
MDedge Pediatrics
Study supports meningococcal B vaccine in children with rare diseases
MDedge Pediatrics
Study offers snapshot of esophageal strictures in EB patients
MDedge Pediatrics
Register Now for NORD’s Rare Impact Awards Celebration
MDedge Pediatrics
2018 Marks 35th Anniversary of NORD and the Orphan Drug Act
MDedge Pediatrics
RFPs Available for the Study of Three Rare Diseases
MDedge Pediatrics